|
Real-time
Euronext Paris
16:21:54 02/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 14.60 EUR | +3.40% |
|
+2.67% | +177.30% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
Chart: Technical Analysis
Stock exchange
Euronext Paris
GNFT 14.60 €
+3.40%
1.12M
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Euronext Paris
| GNFT | 14.60EUR | +3.40% | 1.12M € | |
CBOE
| GNFTp | 14.60EUR | +3.99% | 428K € | |
|
OTC Markets
| GNFTF | 15.75USD | -3.26% | 6.14K $ | |
|
Börse Stuttgart
| XUP | 14.44EUR | +3.88% | 3.91K € | |
|
Xetra
| XUP | 14.08EUR | -1.81% | 2.77K € | |
|
Tradegate
| XUP | 14.22EUR | +0.99% | 1.99K € | |
|
Boerse Muenchen
| XUP | 14.46EUR | +3.58% | 1.81K € | |
|
Deutsche Boerse AG
| XUP | 13.94EUR | -0.71% | 0 € | |
|
London S.E.
| 0QT6 | 14.09EUR | +0.14% | 0 € | |
|
CBOE
| 0QT6 | 14.65EUR | 0.00% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 14.66 | 14.66 | 14.66 |
| Spread/Res. | -0.41% | -0.41% | -0.41% |
| Spread/Supp. | +12.65% | +32.49% | +115.02% |
| Support | 12.96 | 11.02 | 6.79 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GNFT Stock
- Charts GENFIT
Select your edition
All financial news and data tailored to specific country editions
